Association of sCD40 Level in Serum with Risk for Relapse in Graves’ Disease

Trisia Amir, Dwi Suryandari, Fatimah Eliana, Luluk Yunaini, Dwi Yanti

2019

Abstract

CD40 is a transmembrane protein that influences the pathological of autoimmune disease, like Graves’ Disease (GD). Interaction with its ligand (CD40L) on the surface of CD4+ T cells can enhance the humoral immune response. Some studies indicated that GD patients have lower apoptosis in follicular cell. This condition related to sCD40 level, which also can increase autoantibodies in GD patients. The aim of this research was to find out the role of sCD40 as a marker on GD activity. This research was a case-control study comparing 30 relapse patients and 30 non-relapse patients (remission) after treatment with an antithyroid drug was terminated. The subject of this research was serum from both relapse and remission patients, analyzed by ELISA method. Statistical analyzes was independent t-test, a two-tailed p-value less than 0.05 was considered significant. The results, we found that sCD40 levels in serum (pg/ml) increased on relapse patients (1.62± 0.17) compared to remission patients (1.46±0.14) and showed that sCD40 level in serum was significantly different between relapse and remission (p<0.001). These results demonstrated that elevated levels of sCD40 serum, associated with risk for relapse. So, sCD40 may be used as a marker of the active stage of GD.

Download


Paper Citation


in Harvard Style

Amir T., Suryandari D., Eliana F., Yunaini L. and Yanti D. (2019). Association of sCD40 Level in Serum with Risk for Relapse in Graves’ Disease.In Proceedings of the 1st International Conference on Health - Volume 1: ICOH, ISBN 978-989-758-454-1, pages 224-227. DOI: 10.5220/0009589402240227


in Bibtex Style

@conference{icoh19,
author={Trisia Amir and Dwi Suryandari and Fatimah Eliana and Luluk Yunaini and Dwi Yanti},
title={Association of sCD40 Level in Serum with Risk for Relapse in Graves’ Disease},
booktitle={Proceedings of the 1st International Conference on Health - Volume 1: ICOH,},
year={2019},
pages={224-227},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0009589402240227},
isbn={978-989-758-454-1},
}


in EndNote Style

TY - CONF

JO - Proceedings of the 1st International Conference on Health - Volume 1: ICOH,
TI - Association of sCD40 Level in Serum with Risk for Relapse in Graves’ Disease
SN - 978-989-758-454-1
AU - Amir T.
AU - Suryandari D.
AU - Eliana F.
AU - Yunaini L.
AU - Yanti D.
PY - 2019
SP - 224
EP - 227
DO - 10.5220/0009589402240227